Abstract:AbstractQuiescent cancer stem cells (CSC) play important roles in tumorigenesis, relapse, and resistance to chemoradiotherapy. However, the determinants of CSC quiescence and how they sustain themselves to generate tumors and relapse beyond resistance to chemoradiotherapy remains unclear. Here, we found that SET domain–containing protein 4 (SETD4) epigenetically controls breast CSC (BCSC) quiescence by facilitating heterochromatin formation via H4K20me3 catalysis. H4K20me3 localized to the promoter regions and regulated the expression of a set of genes in quiescent BCSCs (qBCSC). SETD4-defined qBCSCs were resistant to chemoradiotherapy and promoted tumor relapse in a mouse model. Upon activation, a SETD4-defined qBCSC sustained itself in a quiescent state by asymmetric division and concurrently produced an active daughter cell that proliferated to produce a cancer cell population. Single-cell sequence analysis indicated that SETD4+ qBCSCs clustered together as a distinct cell type within the heterogeneous BCSC population. SETD4-defined quiescent CSCs were present in multiple cancer types including gastric, cervical, ovarian, liver, and lung cancers and were resistant to chemotherapy. SETD4-defined qBCSCs had a high tumorigenesis potential and correlated with malignancy and chemotherapy resistance in clinical breast cancer patients. Taken together, the results from our previous study and current study on six cancer types reveal an evolutionarily conserved mechanism of cellular quiescence epigenetically controlled by SETD4. Our findings provide insights into the mechanism of tumorigenesis and relapse promoted by SETD4-defined quiescent CSCs and have broad implications for clinical therapies.Significance:These findings advance our knowledge on the epigenetic determinants of quiescence in cancer stem cell populations and pave the way for future pharmacologic developments aimed at targeting drug-resistant quiescent stem cells.

SETD4 Regulates Cell Quiescence and Catalyzes the Trimethylation of H4K20 During Diapause Formation in Artemia

DEK Terminates Diapause by Activation of Quiescent Cells in the Crustacean Artemia.

Acetylation of Chromatin-Associated Histone H3 Lysine 56 Inhibits the Development of Encysted Artemia Embryos.

The Chloride Channel Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Controls Cellular Quiescence by Hyperpolarizing the Cell Membrane During Diapause in the Crustacean Artemia.

Downregulation of a CT10 Regulator of Kinase (crk) Promotes the Formation of Diapause Embryos in the Brine Shrimp Artemia.

The Transcription Factor P8 Regulates Autophagy During Diapause Embryo Formation in Artemia Parthenogenetica

Setd2 Regulates Quiescence and Differentiation of Adult Hematopoietic Stem Cells by Restricting RNA Polymerase II Elongation.

Molecular Characterization and Functional Analyses of a Diapause Hormone Receptor-Like Gene in Parthenogenetic Artemia.

Deubiquitinating Enzyme BAP1 is Involved in the Formation and Maintenance of the Diapause Embryos of Artemia

From ecology to oncology: To understand cancer stem cell dormancy, ask a Brine shrimp (<i>Artemia</i>)

SET Domain-Containing Protein 4 Epigenetically Controls Breast Cancer Stem Cell Quiescence

Expression Profiles of Mirnas and Involvement of Mir-100 and Mir-34 in Regulation of Cell Cycle Arrest in Artemia

The Rna-Editing Deaminase Adar is Involved in Stress Resistance of Artemia Diapause Embryos

SETD4 Cells Contribute to Brain Development and Maintain Adult Stem Cell Reservoir for Neurogenesis.

Involvement of Cyclin K Posttranscriptional Regulation in the Formation of Artemia Diapause Cysts.

From ecology to oncology: To understand cancer stem cell dormancy, ask a Brine shrimp (Artemia)

Activation of an AMP-activated protein kinase is involved in post-diapause development of Artemia franciscana encysted embryos

SETD4 Confers Cancer Stem Cell Chemoresistance in Nonsmall Cell Lung Cancer Patients Via the Epigenetic Regulation of Cellular Quiescence

Signaling Transduction Pathways and G-Protein-Coupled Receptors in Different Stages of the Embryonic Diapause Termination Process in Artemia

Integrating ATAC-Seq and RNA-Seq Reveals the Signal Regulation Involved in the Artemia Embryonic Reactivation Process

Involvement of p90 Ribosomal S6 Kinase in Termination of Cell Cycle Arrest during Development of Artemia-encysted Embryos